下一代测序服务市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按服务、工作流程、最终用户、地区和竞争细分

全球下一代测序服务市场预计在 2024-2028 年预测期内将出现令人印象深刻的增长。这种增长是由于基因组技术的进步、对精准医疗的需求不断增加、下一代测序在临床研究中的应用不断增加以及遗传性疾病患病率的增加而造成的。

发展中国家越来越多地采用 NGS

近年来，发展中国家对下一代测序（NGS）技术的采用一直在稳步增加。预计这一趋势将在未来几年持续下去，并对 NGS 市场的增长产生重大影响。推动发展中国家采用 NGS 的主要因素之一是对更好的医疗服务的需求不断增长。 NGS技术有潜力改善各种疾病的诊断和治疗，包括遗传性疾病、癌症和传染病。随着发展中国家面临着日益沉重的这些疾病负担，NGS 正在成为其医疗保健系统的重要工具。

此外，NGS技术成本的下降和负担得起的测序平台的可用性使得发展中国家更容易采用该技术。此外，许多发展中国家的政府正在投资发展其医疗保健基础设施，其中包括采用 NGS 等先进技术。 NGS 在发展中国家的日益普及预计将成为未来几年 NGS 市场增长的主要推动力。对更好的医疗保健服务不断增长的需求、NGS 技术成本的下降以及政府对医疗保健基础设施的投资是推动这一趋势的关键因素。

基因组技术的进步

基因组技术的进步正在推动未来几年下一代测序 (NGS) 市场的增长。基因组技术的发展使得以更快的速度、更高的准确性和更低的成本对 DNA 和 RNA 进行测序成为可能。这导致NGS技术在临床研究、药物发现、个性化医疗和农业等各个领域得到广泛采用。

基因组技术的重大进步之一是长读长测序技术的发展。长读长测序可提供长 DNA 和 RNA 片段的完整测序，这对于理解结构变异、基因融合和选择性剪接等复杂的遗传变异至关重要。该技术提高了基因组组装的准确性和完整性，使得识别新的遗传变异并增进对疾病遗传基础的理解成为可能。

基因组技术的另一个进步是单细胞测序技术的发展。该技术可以分析单个细胞，从而深入了解细胞异质性和细胞相互作用。单细胞测序正在应用于各个领域，包括癌症研究、神经生物学和发育生物学。因此，这些领域对 NGS 技术的需求不断增长。

此外，基于云的计算平台和生物信息学工具的发展使得分析NGS数据变得更加容易，从而导致NGS市场的增长。这些工具使研究人员能够快速有效地分析大规模基因组数据集，从而获得新的发现并改善患者的治疗结果。

基因组技术的进步正在推动未来几年 NGS 市场的增长。长读长测序、单细胞测序和基于云的计算平台是塑造 NGS 市场未来的一些关键进步。

遗传性疾病患病率不断增加

遗传性疾病患病率的增加是未来几年推动下一代测序（NGS）市场增长的重要因素。遗传性疾病是由个体 DNA 序列异常引起的，可能导致多种健康问题。一些常见的遗传性疾病包括囊性纤维化、镰状细胞性贫血和亨廷顿病。

NGS 技术允许对大部分人类基因组进行快速且经济有效的测序，从而彻底改变了遗传学领域。这项技术使得识别导致各种遗传疾病的基因突变和变异成为可能。因此，NGS 已成为基因研究和临床诊断的重要工具。

遗传性疾病的患病率日益增加，推动了临床诊断中对 NGS 技术的需求。基于NGS的基因检测可以为遗传性疾病患者提供准确、全面的诊断，使医生能够提供更个性化、更有效的治疗方案。此外，基于NGS的基因检测变得越来越便宜和容易获得，使更多患者有可能从这项技术中受益。

除了临床诊断之外，NGS 技术还被用于基因研究，以识别与各种疾病相关的新基因突变和变异。这项研究对于开发遗传性疾病的新疗法和疗法至关重要。遗传性疾病患病率的增加预计将成为未来几年 NGS 市场增长的重要驱动力。 NGS 技术能够对大部分人类基因组进行快速且经济高效的测序，从而使遗传学领域发生了革命性的变化，从而使识别导致各种遗传疾病的基因突变和变异成为可能。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量和验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球下一代测序服务市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按服务分类（人类基因组测序服务、单细胞测序服务、微生物基因组测序服务、基因调控服务、其他）
  • 按工作流程（预测序、测序、数据分析）
  • 按最终用户（医院和诊所、学术和研究机构、製药和生物技术公司、其他）
  • 按地区
  • 按公司划分 (2022)
• 产品图
  • 按服务
  • 按工作流程
  • 按最终用户
  • 按地区

第 6 章：北美下一代测序服务市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按服务
  • 按工作流程
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲下一代测序服务市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按服务
  • 按工作流程
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章：亚太地区下一代测序服务市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按服务
  • 按工作流程
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章：南美洲下一代测序服务市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按服务
  • 按工作流程
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲下一代测序服务市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按服务
  • 按工作流程
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非下一代测序服务
  • 沙特阿拉伯下一代测序服务
  • 阿联酋下一代测序服务

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球下一代测序服务市场：SWOT 分析

第 14 章：波特的五力分析

• 行业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 服务内容
• 最近的发展
• 主要人员
• SWOT分析
  • Quest Diagnostics Incorporated
  • Applied Biological Materials, Inc.
  • Novogene Co, Ltd.
  • Azenta Life Sciences (GENEWIZ)
  • NanoString Technologies, Inc.
  • Illumina, Inc.
  • PacBio, Inc.
  • Gene by Gene Ltd
  • Lucigen Corporation

第 16 章：战略建议

Global Next Generation Sequencing Services Market is expected to see impressive growth during the forecast period, 2024-2028. This growth is accounted for by advancements in genomic technologies, increasing demand for precision medicine, growing application of next-generation sequencing in clinical research, and increasing prevalence of genetic disorders.

Advancements in genomic technologies have led to the development of more advanced and efficient sequencing platforms, which have reduced the cost and time required for sequencing. This has made NGS more accessible to researchers and has driven the growth of the NGS Services Market.

The demand for precision medicine has increased significantly in recent years as researchers and healthcare providers seek to develop personalized treatments for patients based on their unique genetic makeup. NGS services are essential for identifying genetic variations that may be relevant to disease diagnosis, prognosis, and treatment.

NGS is increasingly being used in clinical research, including clinical trials and diagnostic testing. This has led to a growing demand for NGS services in the clinical research industry.

The increasing prevalence of genetic disorders has driven the growth of the NGS Services Market. NGS can be used to diagnose genetic disorders and identify potential treatments, making it an essential tool for genetic testing and diagnosis.

In the past few years, several new NGS services have been launched in the market. For example, in 2020, Illumina launched the NovaSeq 6000 system, which is designed to offer high-throughput sequencing with low per-sample costs. The system uses innovative flow cells and sequencing reagents to deliver high accuracy and cost-effectiveness, making it an attractive option for large-scale sequencing projects.

Thermo Fisher Scientific launched the Ion GeneStudio S5 system in 2019, which is designed to enable fast and accurate NGS for a range of applications. The system offers a compact and scalable design, making it suitable for a range of settings, from small labs to large-scale research facilities. In 2019, Qiagen launched the QIAseq Targeted RNA Panels, which enable researchers to analyze specific gene targets for RNA sequencing. The panels are designed to be compatible with the company's GeneReader NGS system, allowing for a streamlined workflow from sample to result.

However, the market of next-generation sequencing will face several challenges, including data management and analysis, standardization and quality control, regulatory challenges, cost, and data privacy and security. The biggest challenge associated with NGS services is the sheer volume of data generated by the sequencing process. Processing and analyzing this data can be time-consuming and computationally intensive, requiring specialized software and hardware. In addition, the accuracy of the results can be affected by various factors such as sequencing errors, sample contamination, and reference genome quality.

Standardization and quality control are essential to ensure the accuracy and reliability of NGS results. However, there are currently no universally accepted standards for NGS, and quality control can be challenging due to the high variability of samples and sequencing technologies. There is a need for robust quality control procedures that can be applied across different sequencing platforms and laboratories.

Increasing Adoption of NGS in Developing Countries

The adoption of Next Generation Sequencing (NGS) technology in developing countries has been steadily increasing in recent years. This trend is expected to continue in the coming years, and it will have a significant impact on the growth of the NGS market. One of the major factors driving the adoption of NGS in developing countries is the increasing demand for better healthcare services. NGS technology has the potential to improve the diagnosis and treatment of various diseases, including genetic disorders, cancer, and infectious diseases. As developing countries are facing a growing burden of these diseases, NGS is becoming an essential tool for their healthcare systems.

Moreover, the declining cost of NGS technology and the availability of affordable sequencing platforms are making it easier for developing countries to adopt this technology. Additionally, many governments in developing countries are investing in the development of their healthcare infrastructure, which includes the adoption of advanced technologies like NGS. The increasing adoption of NGS in developing countries is expected to be a major driver for the growth of the NGS market in the coming years. The growing demand for better healthcare services, declining costs of NGS technology, and government investments in healthcare infrastructure are the key factors driving this trend.

Advancements in Genomic Technologies

Advancements in genomic technologies are driving the growth of the Next Generation Sequencing (NGS) Market in the coming years. The evolution of genomic technologies has made it possible to sequence DNA and RNA at a faster pace, with greater accuracy, and at a lower cost. This has led to the widespread adoption of NGS technology in various fields, including clinical research, drug discovery, personalized medicine, and agriculture.

One of the significant advancements in genomic technologies is the development of long-read sequencing technology. Long-read sequencing provides complete sequencing of long DNA and RNA fragments, which is critical for understanding complex genetic variations such as structural variants, gene fusions, and alternative splicing. This technology has improved the accuracy and completeness of genome assemblies, making it possible to identify new genetic variants and improve understanding of the genetic basis of diseases.

Another advancement in genomic technologies is the development of single-cell sequencing technology. This technology allows the analysis of individual cells, providing insight into cellular heterogeneity and cellular interactions. Single-cell sequencing is being used in various fields, including cancer research, neurobiology, and developmental biology. As a result, there is a growing demand for NGS technology in these areas.

In addition, the development of cloud-based computing platforms and bioinformatics tools has made it easier to analyze NGS data, leading to the growth of the NGS market. These tools allow researchers to analyze large-scale genomic data sets quickly and efficiently, leading to new discoveries and improved patient outcomes.

Advancements in genomic technologies are driving the growth of the NGS Market in the coming years. Long-read sequencing, single-cell sequencing, and cloud-based computing platforms are some of the key advancements that are shaping the future of the NGS market.

Increasing Prevalence of Genetic Disorders

The increasing prevalence of genetic disorders is a significant factor driving the growth of the Next Generation Sequencing (NGS) market in the coming years. Genetic disorders are caused by abnormalities in an individual's DNA sequence, and they can result in a wide range of health problems. Some of the common genetic disorders include cystic fibrosis, sickle cell anemia, and Huntington's disease.

NGS technology has revolutionized the field of genetics by allowing for the rapid and cost-effective sequencing of large portions of the human genome. This technology has made it possible to identify the genetic mutations and variations that are responsible for various genetic disorders. As a result, NGS has become an essential tool for genetic research and clinical diagnostics.

The increasing prevalence of genetic disorders is driving the demand for NGS technology in clinical diagnostics. NGS-based genetic testing can provide accurate and comprehensive diagnoses for patients with genetic disorders, enabling doctors to provide more personalized and effective treatment plans. Moreover, NGS-based genetic testing is becoming increasingly affordable and accessible, making it possible for more patients to benefit from this technology.

In addition to clinical diagnostics, NGS technology is being used in genetic research to identify new genetic mutations and variations associated with various diseases. This research is critical for developing new treatments and therapies for genetic disorders. The increasing prevalence of genetic disorders is expected to be a significant driver for the growth of the NGS Market in the coming years. NGS technology has revolutionized the field of genetics by enabling the rapid and cost-effective sequencing of large portions of the human genome, making it possible to identify the genetic mutations and variations responsible for various genetic disorders.

Market Segmentation

Global Next Generation Sequencing Services Market can be segmented based on service, workflow, end user, and region. Based on service, the market can be divided into human genome sequencing services, single-cell sequencing services, microbial genome-based sequencing services, gene regulation services, and others. Based on workflow, the market is divided into pre-sequencing, sequencing, and data analysis. Based on end users, the market is divided into hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology companies, and others. Regionally, the Next Generation Sequencing Services Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Quest Diagnostics Incorporated, Applied Biological Materials, Inc., Novogene Co, Ltd., Azenta Life Sciences (GENEWIZ), NanoString Technologies, Inc., Illumina, Inc., PacBio, Inc., Gene by Gene Ltd, Lucigen Corporation are some of the leading players operating in the Global Next Generation Sequencing Services Market.

Report Scope:

In this report, Global Next Generation Sequencing Services Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Next Generation Sequencing Services Market, By Service:

• Human Genome Sequencing Services
• Single Cell Sequencing Services
• Microbial Genome-based Sequencing Services
• Gene Regulation Services
• Others

Next Generation Sequencing Services Market, By Workflow:

• Pre-Sequencing
• Sequencing
• Data Analysis

Next Generation Sequencing Services Market, By Workflow:

• Hospitals & Clinics
• Academic & Research Institutions
• Pharmaceutical & Biotechnology Companies
• Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing Services Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Human Genome Sequencing Services, Single Cell Sequencing Services, Microbial Genome-based Sequencing Services, Gene Regulation Services, Others)
  • 5.2.2. By Workflow (Pre-Sequencing, Sequencing, Data Analysis)
  • 5.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Product Map
  • 5.3.1. By Service
  • 5.3.2. By Workflow
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Next Generation Sequencing Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Workflow
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Next Generation Sequencing Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Workflow
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Next Generation Sequencing Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Workflow
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Next Generation Sequencing Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Workflow
      • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Workflow
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Next Generation Sequencing Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Workflow
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Next Generation Sequencing Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Workflow
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Next Generation Sequencing Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Workflow
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Next Generation Sequencing Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Workflow
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Next Generation Sequencing Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Workflow
      • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Workflow
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Next Generation Sequencing Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Workflow
      • 8.3.1.2.3. By End User
  • 8.3.2. India Next Generation Sequencing Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Workflow
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Next Generation Sequencing Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Workflow
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Next Generation Sequencing Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Workflow
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Next Generation Sequencing Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Workflow
      • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Workflow
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Next Generation Sequencing Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Workflow
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Next Generation Sequencing Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Workflow
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Next Generation Sequencing Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Workflow
      • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Workflow
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Next Generation Sequencing Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Workflow
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Next Generation Sequencing Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Workflow
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Next Generation Sequencing Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Workflow
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Next Generation Sequencing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Quest Diagnostics Incorporated
  • 15.5.2. Applied Biological Materials, Inc.
  • 15.5.3. Novogene Co, Ltd.
  • 15.5.4. Azenta Life Sciences (GENEWIZ)
  • 15.5.5. NanoString Technologies, Inc.
  • 15.5.6. Illumina, Inc.
  • 15.5.7. PacBio, Inc.
  • 15.5.8. Gene by Gene Ltd
  • 15.5.9. Lucigen Corporation

16. Strategic Recommendations